TickerFacts.

Viatris Inc (VTRS): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$135.20M
Year ended 2025-12-31
$2.72B
Trailing 12 months to 2026-06-30
-69.2%
3-year compound annual growth
-41.7%
5-year compound annual growth
$4.64B2018-12-31: $3.02B2019-12-31: $2.73B2020-12-31: $2.01B2021-12-31: $4.47B2022-12-31: $4.64B2023-12-31: $3.51B2024-12-31: $2.90B2025-12-31: $135.20M$135.20M
2018-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$135.20M-95.3%2026-02-26, From 2025-01-01
2024-12-31$2.90B-17.2%2026-02-26, From 2024-01-01
2023-12-31$3.51B-24.5%2026-02-26, From 2023-01-01
2022-12-31$4.64B+3.8%2025-02-27, From 2022-01-01
2021-12-31$4.47B+123.0%2024-02-28, From 2021-01-01
2020-12-31$2.01B-26.7%2023-02-27, From 2020-01-01
2019-12-31$2.73B-9.3%2022-02-28, From 2019-01-01
2018-12-31$3.02Bn/a2021-03-01, From 2018-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Viatris Inc (VTRS)2025-12-31$135.20M-95.3%
Regeneron Pharmaceuticals, Inc. (REGN)2025-12-31$4.12B-7.9%
Vertex Pharmaceuticals Inc (VRTX)2025-12-31$4.38Bn/m
Teva Pharmaceutical Industries Ltd (TEVA)2025-12-31$3.16B+317.9%
Bausch Health Companies Inc. (BHC)2025-12-31$3.02B+7.4%
BeOne Medicines Ltd. (ONC)2025-12-31$588.82Mn/m
Jazz Pharmaceuticals plc (JAZZ)2025-12-31-$388.64Mn/m
Perrigo Co PLC (PRGO)2025-12-31-$784.70Mn/m
Alnylam Pharmaceuticals, Inc. (ALNY)2025-12-31$557.24Mn/m

Compare VTRS, REGN, VRTX, TEVA side by side · Screen every company in Pharmaceutical Preparations ↗